Feedback / Questions
laruparetigene zovaparvovec (AGTC-501) - AGTC
https://www.prnewswire.com/news-releases/beacon-therapeutics-granted-fda-regenerative-medicine-advanced-therapy-rmat-designation-for-laru-zova-agtc-501-302361416.html
Jan 28, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next